Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF846 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | DNAJA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | ETV6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | KLF12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | RBMXL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | STK31 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | AIFM1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | HGD | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | ZNF85 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | TBC1D14 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |